Literature DB >> 18172591

Bridging therapy in oral anticoagulated patients: focusing on how to do it.

G Palareti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18172591     DOI： 10.1007/s11739-007-0074-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

1.  Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery.

Authors:  J D Douketis; M A Crowther; S S Cherian; C B Kearon
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 2.  The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.

Authors:  Caterina Mannucci; James D Douketis
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  To bridge or not to bridge, that is the question.

Authors:  A C Spyropoulos
Journal:  Intern Emerg Med       Date:  2007-07-18       Impact factor: 3.397

Review 4.  Management of anticoagulation before and after elective surgery.

Authors:  C Kearon; J Hirsh
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

5.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

6.  Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Authors:  A C Spyropoulos; A G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; F J Frost
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

7.  The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.

Authors:  Xin Yang; Karen P Alexander; Anita Y Chen; Matthew T Roe; Ralph G Brindis; Sunil V Rao; W Brian Gibler; E Magnus Ohman; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2005-09-29       Impact factor: 24.094

8.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors:  R O Bonow; B Carabello; A C de Leon; L H Edmunds; B J Fedderly; M D Freed; W H Gaasch; C R McKay; R A Nishimura; P T O'Gara; R A O'Rourke; S H Rahimtoola; J L Ritchie; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R J Gibbons; R O Russell; T J Ryan; S C Smith
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

10.  Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.

Authors:  V V Kakkar; A T Cohen; R A Edmonson; M J Phillips; D J Cooper; S K Das; K T Maher; R M Sanderson; V P Ward; S Kakkar
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.